Literature DB >> 33375175

C-type Lectin CD209L/L-SIGN and CD209/DC-SIGN: Cell Adhesion Molecules Turned to Pathogen Recognition Receptors.

Nader Rahimi1.   

Abstract

C-type lectin CD209/DC-SIGN and CD209L/L-SIGN proteins are distinct cell adhesion and pathogen recognition receptors that mediate cellular interactions and recognize a wide range of pathogens, including viruses such as SARS, SARS-CoV-2, bacteria, fungi and parasites. Pathogens exploit CD209 family proteins to promote infection and evade the immune recognition system. CD209L and CD209 are widely expressed in SARS-CoV-2 target organs and can contribute to infection and pathogenesis. CD209 family receptors are highly susceptible to alternative splicing and genomic polymorphism, which may influence virus tropism and transmission in vivo. The carbohydrate recognition domain (CRD) and the neck/repeat region represent the key features of CD209 family proteins that are also central to facilitating cellular ligand interactions and pathogen recognition. While the neck/repeat region is involved in oligomeric dimerization, the CRD recognizes the mannose-containing structures present on specific glycoproteins such as those found on the SARS-CoV-2 spike protein. Considering the role of CD209L and related proteins in diverse pathogen recognition, this review article discusses the recent advances in the cellular and biochemical characterization of CD209 and CD209L and their roles in viral uptake, which has important implications in understanding the host-pathogen interaction, the viral pathobiology and driving vaccine development of SARS-CoV-2.

Entities:  

Keywords:  C-type lectin; C-type lectin domain family 4 member M; CD209; CD209L; CLEC4G; CLEC4M; COVID-19; DC-SIGN; L-SIGN; LSECtin; SARS-CoV-2; cell adhesion molecule

Year:  2020        PMID: 33375175      PMCID: PMC7822156          DOI: 10.3390/biology10010001

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  115 in total

1.  Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

Authors:  T B Geijtenbeek; R Torensma; S J van Vliet; G C van Duijnhoven; G J Adema; Y van Kooyk; C G Figdor
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

2.  C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.

Authors:  Sonja I Gringhuis; Jeroen den Dunnen; Manja Litjens; Bert van Het Hof; Yvette van Kooyk; Teunis B H Geijtenbeek
Journal:  Immunity       Date:  2007-04-26       Impact factor: 31.745

3.  Determination of DC-SIGN and DC-SIGNR repeat region variations.

Authors:  Huanliang Liu; Tuofu Zhu
Journal:  Methods Mol Biol       Date:  2005

4.  Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.

Authors:  Laura Burleigh; Pierre-Yves Lozach; Cécile Schiffer; Isabelle Staropoli; Valérie Pezo; Françoise Porrot; Bruno Canque; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Ali Amara
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN.

Authors:  Sarah L Londrigan; Stuart G Turville; Michelle D Tate; Yi-Mo Deng; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

6.  pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.

Authors:  Zhi-Yong Yang; Yue Huang; Lakshmanan Ganesh; Kwanyee Leung; Wing-Pui Kong; Owen Schwartz; Kanta Subbarao; Gary J Nabel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

8.  The structure of DC-SIGNR with a portion of its repeat domain lends insights to modeling of the receptor tetramer.

Authors:  Greg A Snyder; Marco Colonna; Peter D Sun
Journal:  J Mol Biol       Date:  2005-04-15       Impact factor: 5.469

9.  Autonomous tetramerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR.

Authors:  Quan D Yu; Asa P Oldring; Alex S Powlesland; Cynthia K W Tso; Chunxuan Yang; Kurt Drickamer; Maureen E Taylor
Journal:  J Mol Biol       Date:  2009-02-26       Impact factor: 5.469

Review 10.  Bitter-sweet symphony: glycan-lectin interactions in virus biology.

Authors:  Wander Van Breedam; Stefan Pöhlmann; Herman W Favoreel; Raoul J de Groot; Hans J Nauwynck
Journal:  FEMS Microbiol Rev       Date:  2013-12-06       Impact factor: 16.408

View more
  15 in total

Review 1.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

2.  Comprehensive Profiling Analysis of CD209 in Malignancies Reveals the Therapeutic Implication for Tumor Patients Infected With SARS-CoV-2.

Authors:  Jinyuan Li; Shuzhao Chen; Yang Li; Ziang Zhu; Hanying Huang; Weida Wang; Yao Yang; Yang Liang; Lingling Shu
Journal:  Front Genet       Date:  2022-06-17       Impact factor: 4.772

3.  Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein.

Authors:  Ilaria Varotto-Boccazzi; Micaela Garziano; Giulia Maria Cattaneo; Beatrice Bisaglia; Paolo Gabrieli; Mara Biasin; Alessandro Manenti; Diego Rubolini; Mario Clerici; Emanuele Montomoli; Gian Vincenzo Zuccotti; Daria Trabattoni; Sara Epis; Claudio Bandi
Journal:  Vaccines (Basel)       Date:  2022-05-19

4.  Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.

Authors:  Tal Noy-Porat; Adva Mechaly; Yinon Levy; Efi Makdasi; Ron Alcalay; David Gur; Moshe Aftalion; Reut Falach; Shani Leviatan Ben-Arye; Shirley Lazar; Ayelet Zauberman; Eyal Epstein; Theodor Chitlaru; Shay Weiss; Hagit Achdout; Jonathan D Edgeworth; Raghavendra Kikkeri; Hai Yu; Xi Chen; Shmuel Yitzhaki; Shmuel C Shapira; Vered Padler-Karavani; Ohad Mazor; Ronit Rosenfeld
Journal:  iScience       Date:  2021-04-26

Review 5.  What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders.

Authors:  Enrico Maggi; Bruno Giuseppe Azzarone; Giorgio Walter Canonica; Lorenzo Moretta
Journal:  Allergy       Date:  2021-10-12       Impact factor: 14.710

6.  Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells.

Authors:  Razie Amraei; Chaoshuang Xia; Judith Olejnik; Mitchell R White; Marc A Napoleon; Saran Lotfollahzadeh; Blake M Hauser; Aaron G Schmidt; Vipul Chitalia; Elke Mühlberger; Catherine E Costello; Nader Rahimi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-08       Impact factor: 11.205

Review 7.  SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.

Authors:  Evgenii Gusev; Alexey Sarapultsev; Liliya Solomatina; Valeriy Chereshnev
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

Review 8.  Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis.

Authors:  Dermot Cox
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

9.  CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.

Authors:  Razie Amraei; Wenqing Yin; Marc A Napoleon; Ellen L Suder; Jacob Berrigan; Qing Zhao; Judith Olejnik; Kevin Brown Chandler; Chaoshuang Xia; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Aaron G Schmidt; Suryaram Gummuluru; Elke Mühlberger; Vipul Chitalia; Catherine E Costello; Nader Rahimi
Journal:  ACS Cent Sci       Date:  2021-06-30       Impact factor: 18.728

Review 10.  Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.

Authors:  Annick Barre; Els J M Van Damme; Mathias Simplicien; Sophie Le Poder; Bernard Klonjkowski; Hervé Benoist; David Peyrade; Pierre Rougé
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.